1
|
Xu J, Liu X, Zhao F, Zhang Y, Wang Z. HIF1α overexpression enhances diabetic wound closure in high glucose and low oxygen conditions by promoting adipose-derived stem cell paracrine function and survival. Stem Cell Res Ther 2020; 11:148. [PMID: 32248837 PMCID: PMC7132964 DOI: 10.1186/s13287-020-01654-2] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2019] [Revised: 03/11/2020] [Accepted: 03/17/2020] [Indexed: 12/31/2022] Open
Abstract
Background Adipose-derived stem cell (ADSC) transplantation is a promising strategy to promote wound healing because of the paracrine function of stem cells. However, glucose-associated effects on stem cell paracrine function and survival contribute to impaired wound closure in patients with diabetes, limiting the efficacy of ADSC transplantation. Hypoxia-inducible factor (HIF)1α plays important roles in wound healing, and in this study, we investigated the effects of HIF1α overexpression on ADSCs in high glucose and low oxygen conditions. Methods Adipose samples were obtained from BALB/C mice, and ADSCs were cultured in vitro by digestion. Control and HIF1α-overexpressing ADSCs were induced by transduction. The mRNA and protein levels of angiogenic growth factors in control and HIF1α-overexpressing ADSCs under high glucose and low oxygen conditions were analyzed by quantitative reverse transcription-polymerase chain reaction and western blotting. The effects of ADSC HIF1α overexpression on the proliferation and migration of mouse aortic endothelial cells (MAECs) under high glucose were evaluated using an in vitro coculture model. Intracellular reactive oxygen species (ROS) and 8-hydroxydeoxyguanosine (8-OHdG) levels in ADSCs were observed using 2,7-dichlorodihydrofluorescein diacetate staining and enzyme-linked immunosorbent assays, respectively. Apoptosis and cell cycle analysis assays were performed by flow cytometry. An in vivo full-thickness skin defect mouse model was used to evaluate the effects of transplanted ADSCs on diabetic wound closure. Results In vitro, HIF1α overexpression in ADSCs significantly increased the expression of vascular endothelial growth factor A, fibroblast growth factor 2, and C-X-C motif chemokine ligand 12, which were inhibited by high glucose. HIF1α overexpression in ADSCs alleviated high glucose-induced defects in MAEC proliferation and migration and significantly suppressed ADSC ROS and 8-OHdG levels, thereby decreasing apoptosis and enhancing survival. In vivo, HIF1α overexpression in ADSCs prior to transplantation significantly enhanced angiogenic growth factor expression, promoting wound closure in diabetic mice. Conclusions HIF1α overexpression in ADSCs efficiently alleviates high glucose-induced paracrine dysfunction, decreases oxidative stress and subsequent DNA damage, improves viability, and enhances the therapeutic effects of ADSCs on diabetic wound healing.
Collapse
Affiliation(s)
- Jin Xu
- Department of Surgery, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, China
| | - Xiaoyu Liu
- Department of Obstetrics and Gynecology, Reproductive Medicine Center, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, China
| | - Feng Zhao
- Department of Stem Cells and Regenerative Medicine, Shenyang Key Laboratory for Stem Cells and Regenerative Medicine, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, No. 77 Puhe Street, Shenbei New District, Shenyang, 110122, China
| | - Ying Zhang
- Department of Pathology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, China
| | - Zhe Wang
- Department of Pathology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, China.
| |
Collapse
|
8
|
Negmadjanov U, Godic Z, Rizvi F, Emelyanova L, Ross G, Richards J, Holmuhamedov EL, Jahangir A. TGF-β1-mediated differentiation of fibroblasts is associated with increased mitochondrial content and cellular respiration. PLoS One 2015; 10:e0123046. [PMID: 25849590 PMCID: PMC4388650 DOI: 10.1371/journal.pone.0123046] [Citation(s) in RCA: 73] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2014] [Accepted: 02/18/2015] [Indexed: 12/22/2022] Open
Abstract
Objectivs Cytokine-dependent activation of fibroblasts to myofibroblasts, a key event in fibrosis, is accompanied by phenotypic changes with increased secretory and contractile properties dependent on increased energy utilization, yet changes in the energetic profile of these cells are not fully described. We hypothesize that the TGF-β1-mediated transformation of myofibroblasts is associated with an increase in mitochondrial content and function when compared to naive fibroblasts. Methods Cultured NIH/3T3 mouse fibroblasts treated with TGF-β1, a profibrotic cytokine, or vehicle were assessed for transformation to myofibroblasts (appearance of α-smooth muscle actin [α-SMA] stress fibers) and associated changes in mitochondrial content and functions using laser confocal microscopy, Seahorse respirometry, multi-well plate reader and biochemical protocols. Expression of mitochondrial-specific proteins was determined using western blotting, and the mitochondrial DNA quantified using Mitochondrial DNA isolation kit. Results Treatment with TGF-β1 (5 ng/mL) induced transformation of naive fibroblasts into myofibroblasts with a threefold increase in the expression of α-SMA (6.85 ± 0.27 RU) compared to cells not treated with TGF-β1 (2.52 ± 0.11 RU). TGF-β1 exposure increased the number of mitochondria in the cells, as monitored by membrane potential sensitive dye tetramethylrhodamine, and expression of mitochondria-specific proteins; voltage-dependent anion channels (0.54 ± 0.05 vs. 0.23 ± 0.05 RU) and adenine nucleotide transporter (0.61 ± 0.11 vs. 0.22 ± 0.05 RU), as well as mitochondrial DNA content (530 ± 12 μg DNA/106 cells vs. 307 ± 9 μg DNA/106 cells in control). TGF-β1 treatment was associated with an increase in mitochondrial function with a twofold increase in baseline oxygen consumption rate (2.25 ± 0.03 vs. 1.13 ± 0.1 nmol O2/min/106 cells) and FCCP-induced mitochondrial respiration (2.87 ± 0.03 vs. 1.46 ± 0.15 nmol O2/min/106 cells). Conclusions TGF-β1 induced differentiation of fibroblasts is accompanied by energetic remodeling of myofibroblasts with an increase in mitochondrial respiration and mitochondrial content.
Collapse
Affiliation(s)
- Ulugbek Negmadjanov
- Sheikh Khalifa bin Hamad Al Thani Center for Integrative Research on Cardiovascular Aging, Aurora Research Institute, Aurora Health Care, Milwaukee, Wisconsin, 53215, United States of America
| | - Zarko Godic
- Sheikh Khalifa bin Hamad Al Thani Center for Integrative Research on Cardiovascular Aging, Aurora Research Institute, Aurora Health Care, Milwaukee, Wisconsin, 53215, United States of America
| | - Farhan Rizvi
- Sheikh Khalifa bin Hamad Al Thani Center for Integrative Research on Cardiovascular Aging, Aurora Research Institute, Aurora Health Care, Milwaukee, Wisconsin, 53215, United States of America
| | - Larisa Emelyanova
- Sheikh Khalifa bin Hamad Al Thani Center for Integrative Research on Cardiovascular Aging, Aurora Research Institute, Aurora Health Care, Milwaukee, Wisconsin, 53215, United States of America
| | - Gracious Ross
- Sheikh Khalifa bin Hamad Al Thani Center for Integrative Research on Cardiovascular Aging, Aurora Research Institute, Aurora Health Care, Milwaukee, Wisconsin, 53215, United States of America
| | - John Richards
- Laboratory of Immunology, Aurora Health Care, Milwaukee, Wisconsin, 53215, United States of America
| | - Ekhson L. Holmuhamedov
- Sheikh Khalifa bin Hamad Al Thani Center for Integrative Research on Cardiovascular Aging, Aurora Research Institute, Aurora Health Care, Milwaukee, Wisconsin, 53215, United States of America
| | - Arshad Jahangir
- Sheikh Khalifa bin Hamad Al Thani Center for Integrative Research on Cardiovascular Aging, Aurora Research Institute, Aurora Health Care, Milwaukee, Wisconsin, 53215, United States of America
- Aurora Cardiovascular Services, Aurora Health Care, Milwaukee, Wisconsin, 53215, United States of America
- * E-mail:
| |
Collapse
|
9
|
Zhang M, Hagenmueller M, Riffel JH, Kreusser MM, Bernhold E, Fan J, Katus HA, Backs J, Hardt SE. Calcium/calmodulin-dependent protein kinase II couples Wnt signaling with histone deacetylase 4 and mediates dishevelled-induced cardiomyopathy. Hypertension 2014; 65:335-44. [PMID: 25489064 DOI: 10.1161/hypertensionaha.114.04467] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Activation of Wnt signaling results in maladaptive cardiac remodeling and cardiomyopathy. Recently, calcium/calmodulin-dependent protein kinase II (CaMKII) was reported to be a pivotal participant in myocardial remodeling. Because CaMKII was suggested as a downstream target of noncanonical Wnt signaling, we aimed to elucidate the role of CaMKII in dishevelled-1-induced cardiomyopathy and the mechanisms underlying its function. Dishevelled-1-induced cardiomyopathy was reversed by deletion of neither CaMKIIδ nor CaMKIIγ. Therefore, dishevelled-1-transgenic mice were crossed with CaMKIIδγ double-knockout mice. These mice displayed a normal cardiac phenotype without cardiac hypertrophy, fibrosis, apoptosis, or left ventricular dysfunction. Further mechanistic analyses unveiled that CaMKIIδγ couples noncanonical Wnt signaling to histone deacetylase 4 and myosin enhancer factor 2. Therefore, our findings indicate that the axis, consisting of dishevelled-1, CaMKII, histone deacetylase 4, and myosin enhancer factor 2, is an attractive therapeutic target for prevention of cardiac remodeling and its progression to left ventricular dysfunction.
Collapse
Affiliation(s)
- Min Zhang
- From the Department of Cardiology, Angiology, and Pulmology (M.Z., M.H., J.H.R., M.M.K., E.B., J.F., H.A.K., S.E.H.) and Research Unit Cardiac Epigenetics, Department of Cardiology (M.M.K., J.B.), University of Heidelberg, Heidelberg, Germany; Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (M.Z.); DZHK (German Center for Cardiovascular Research) (M.H., J.H.R., M.M.K., H.A.K., S.E.H., M.M.K., J.B.), Partner Site Heidelberg/Mannheim, Heidelberg, Germany; and Center for Cardiac and Circulatory Diseases, Bruchsal, Germany (S.E.H.)
| | - Marco Hagenmueller
- From the Department of Cardiology, Angiology, and Pulmology (M.Z., M.H., J.H.R., M.M.K., E.B., J.F., H.A.K., S.E.H.) and Research Unit Cardiac Epigenetics, Department of Cardiology (M.M.K., J.B.), University of Heidelberg, Heidelberg, Germany; Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (M.Z.); DZHK (German Center for Cardiovascular Research) (M.H., J.H.R., M.M.K., H.A.K., S.E.H., M.M.K., J.B.), Partner Site Heidelberg/Mannheim, Heidelberg, Germany; and Center for Cardiac and Circulatory Diseases, Bruchsal, Germany (S.E.H.)
| | - Johannes H Riffel
- From the Department of Cardiology, Angiology, and Pulmology (M.Z., M.H., J.H.R., M.M.K., E.B., J.F., H.A.K., S.E.H.) and Research Unit Cardiac Epigenetics, Department of Cardiology (M.M.K., J.B.), University of Heidelberg, Heidelberg, Germany; Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (M.Z.); DZHK (German Center for Cardiovascular Research) (M.H., J.H.R., M.M.K., H.A.K., S.E.H., M.M.K., J.B.), Partner Site Heidelberg/Mannheim, Heidelberg, Germany; and Center for Cardiac and Circulatory Diseases, Bruchsal, Germany (S.E.H.)
| | - Michael M Kreusser
- From the Department of Cardiology, Angiology, and Pulmology (M.Z., M.H., J.H.R., M.M.K., E.B., J.F., H.A.K., S.E.H.) and Research Unit Cardiac Epigenetics, Department of Cardiology (M.M.K., J.B.), University of Heidelberg, Heidelberg, Germany; Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (M.Z.); DZHK (German Center for Cardiovascular Research) (M.H., J.H.R., M.M.K., H.A.K., S.E.H., M.M.K., J.B.), Partner Site Heidelberg/Mannheim, Heidelberg, Germany; and Center for Cardiac and Circulatory Diseases, Bruchsal, Germany (S.E.H.)
| | - Elmar Bernhold
- From the Department of Cardiology, Angiology, and Pulmology (M.Z., M.H., J.H.R., M.M.K., E.B., J.F., H.A.K., S.E.H.) and Research Unit Cardiac Epigenetics, Department of Cardiology (M.M.K., J.B.), University of Heidelberg, Heidelberg, Germany; Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (M.Z.); DZHK (German Center for Cardiovascular Research) (M.H., J.H.R., M.M.K., H.A.K., S.E.H., M.M.K., J.B.), Partner Site Heidelberg/Mannheim, Heidelberg, Germany; and Center for Cardiac and Circulatory Diseases, Bruchsal, Germany (S.E.H.)
| | - Jingjing Fan
- From the Department of Cardiology, Angiology, and Pulmology (M.Z., M.H., J.H.R., M.M.K., E.B., J.F., H.A.K., S.E.H.) and Research Unit Cardiac Epigenetics, Department of Cardiology (M.M.K., J.B.), University of Heidelberg, Heidelberg, Germany; Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (M.Z.); DZHK (German Center for Cardiovascular Research) (M.H., J.H.R., M.M.K., H.A.K., S.E.H., M.M.K., J.B.), Partner Site Heidelberg/Mannheim, Heidelberg, Germany; and Center for Cardiac and Circulatory Diseases, Bruchsal, Germany (S.E.H.)
| | - Hugo A Katus
- From the Department of Cardiology, Angiology, and Pulmology (M.Z., M.H., J.H.R., M.M.K., E.B., J.F., H.A.K., S.E.H.) and Research Unit Cardiac Epigenetics, Department of Cardiology (M.M.K., J.B.), University of Heidelberg, Heidelberg, Germany; Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (M.Z.); DZHK (German Center for Cardiovascular Research) (M.H., J.H.R., M.M.K., H.A.K., S.E.H., M.M.K., J.B.), Partner Site Heidelberg/Mannheim, Heidelberg, Germany; and Center for Cardiac and Circulatory Diseases, Bruchsal, Germany (S.E.H.)
| | - Johannes Backs
- From the Department of Cardiology, Angiology, and Pulmology (M.Z., M.H., J.H.R., M.M.K., E.B., J.F., H.A.K., S.E.H.) and Research Unit Cardiac Epigenetics, Department of Cardiology (M.M.K., J.B.), University of Heidelberg, Heidelberg, Germany; Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (M.Z.); DZHK (German Center for Cardiovascular Research) (M.H., J.H.R., M.M.K., H.A.K., S.E.H., M.M.K., J.B.), Partner Site Heidelberg/Mannheim, Heidelberg, Germany; and Center for Cardiac and Circulatory Diseases, Bruchsal, Germany (S.E.H.)
| | - Stefan E Hardt
- From the Department of Cardiology, Angiology, and Pulmology (M.Z., M.H., J.H.R., M.M.K., E.B., J.F., H.A.K., S.E.H.) and Research Unit Cardiac Epigenetics, Department of Cardiology (M.M.K., J.B.), University of Heidelberg, Heidelberg, Germany; Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (M.Z.); DZHK (German Center for Cardiovascular Research) (M.H., J.H.R., M.M.K., H.A.K., S.E.H., M.M.K., J.B.), Partner Site Heidelberg/Mannheim, Heidelberg, Germany; and Center for Cardiac and Circulatory Diseases, Bruchsal, Germany (S.E.H.).
| |
Collapse
|